Skip to content

Chronic pain review finds uncertain evidence of changes in the body's opioid system

Pooled beta-endorphin measurements did not differ significantly between patients and pain-free controls, while preliminary receptor findings suggested a different avenue for research.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The pooled analyses did not find statistically significant differences in beta-endorphin levels between patients and pain-free controls, but the evidence was rated very low. Some studies suggested altered opioid receptors in fibromyalgia. Together, these findings leave the biological explanation unsettled and do not establish a cause of pain or a treatment benefit.

Keep in mind

The authors identify small samples and inadequate study methods as major limitations. Very low evidence certainty makes the nonsignificant beta-endorphin result insufficient to establish that levels are equivalent.

THE RESULT, WITH CONTEXT

What researchers found

No statistically significant difference

Beta-endorphin levels in blood and cerebrospinal fluid

Fibromyalgia or chronic low back pain versus pain-free controls in pooled analyses. Measurement timing and numerical effect estimates were not reported.

Eur J Pain, 2026 · Original source ↓

Different biological measurements

The review examined opioid substances produced within the body as well as receptor expression and availability. These are different measurements, so an uncertain finding about substance levels does not resolve questions about receptor function.

A tentative receptor signal

Some fibromyalgia studies suggested reduced receptor binding in the brain and lower receptor expression in immune cells. The abstract presents this as a possible feature requiring clarification, without demonstrating its role in causing symptoms.

CHECK THE ORIGINAL

The original publication

A Systematic Review With Meta-Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia.

Bruun KD, Moerkeberg MCR, Pedersen JR et al.
Eur J Pain · 2026

PubMed ID
41457418
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.